FDA Inspection 1206636 — Apicore Pharmaceuticals Private Ltd

Apicore Pharmaceuticals Private Ltd — FEI 3006767695

The FDA completed an inspection of Apicore Pharmaceuticals Private Ltd on May 5, 2023 in Vadodara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 5, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vadodara (India)